NEUROPHET, Inc. (KOSDAQ:380550)

NEUROPHET Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024
Period Ending	Dec 31, 2025	Dec 31, 2024
Net Income	-22,389	-15,101
Depreciation & Amortization	1,110	1,095
Loss (Gain) From Sale of Assets	0.08	3.48
Stock-Based Compensation	591.83	552.27
Provision & Write-off of Bad Debts	347.3	0.13
Other Operating Activities	5,962	942.32
Change in Accounts Receivable	-172.55	-144.57
Change in Inventory	-20.59	13.08
Change in Other Net Operating Assets	-496.55	26.95
Operating Cash Flow	-15,067	-12,613
Capital Expenditures	-265.46	-248.74
Sale of Property, Plant & Equipment	0.51	6.86
Sale (Purchase) of Intangibles	-59.47	-143.25
Investment in Securities	-16,100	9,000
Other Investing Activities	66.93	3
Investing Cash Flow	-16,357	8,618
Long-Term Debt Issued	5,000	-
Long-Term Debt Repaid	-625.6	-655.84
Net Debt Issued (Repaid)	4,374	-655.84
Issuance of Common Stock	28,141	-
Financing Cash Flow	32,516	342.21
Foreign Exchange Rate Adjustments	-7.23	0.92
Net Cash Flow	1,084	-3,652
Free Cash Flow	-15,332	-12,862
Free Cash Flow Margin	-586.30%	-580.35%
Free Cash Flow Per Share	-1576.43	-3484.24
Cash Interest Paid	48.52	0
Cash Income Tax Paid	-52.13	49.81
Levered Free Cash Flow	-39,964	-
Unlevered Free Cash Flow	-39,389	-
Change in Working Capital	-689.69	-104.55

Source: S&P Global Market Intelligence. Standard template. Financial Sources.